CAR-T cell therapy Archives - Express Pharma

Nucelion Therapeutics, VeGen Bio collaborate on CAR-T cell therapy manufacturing

Mankind Pharma to acquire 70% stake in Armed Cell Therapeutics for EUR 48 million

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

THSTI, Miltenyi Biotec and BIRAC launch India’s first hands-on training on cell and gene therapy manufacturing

Indian Society for Clinical Research appoints Dr Seema Pai as President

Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma

Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma

Revolutionising cancer treatment: The promise of point-of-care CAR-T therapy

US FDA gives record number of review designations to CRISPR drugs in 2023: GlobalData

ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle: GlobalData